Although the role of HER-2 in this tumor has already been extensively investigated [19], and found to be frequently associated with invasion, high grade, and unfavorable prognosis, its overall prognostic role remains controversial [20-24] and appears to be stage-dependent. The gene discussed is ERBB2; the disease is neoplasm.